Parallel Advisors’s Regenxbio RGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $550 | Buy |
67
+17
| +34% | +$140 | ﹤0.01% | 3270 |
|
|
2025
Q1 | $358 | Hold |
50
| – | – | ﹤0.01% | 3278 |
|
|
2024
Q4 | $387 | Hold |
50
| – | – | ﹤0.01% | 3252 |
|
|
2024
Q3 | $525 | Hold |
50
| – | – | ﹤0.01% | 3158 |
|
|
2024
Q2 | $585 | Hold |
50
| – | – | ﹤0.01% | 3056 |
|
|
2024
Q1 | $1.05K | Hold |
50
| – | – | ﹤0.01% | 2922 |
|
|
2023
Q4 | $898 | Hold |
50
| – | – | ﹤0.01% | 2958 |
|
|
2023
Q3 | $823 | Hold |
50
| – | – | ﹤0.01% | 3007 |
|
|
2023
Q2 | $1K | Sell |
50
-4
| -7% | -$80 | ﹤0.01% | 2932 |
|
|
2023
Q1 | $1.02K | Hold |
54
| – | – | ﹤0.01% | 2952 |
|
|
2022
Q4 | $1.23K | Hold |
54
| – | – | ﹤0.01% | 2851 |
|
|
2022
Q3 | $1K | Sell |
54
-7
| -11% | -$130 | ﹤0.01% | 2978 |
|
|
2022
Q2 | $2K | Buy |
61
+11
| +22% | +$361 | ﹤0.01% | 2605 |
|
|
2022
Q1 | $2K | Sell |
50
-18
| -26% | -$720 | ﹤0.01% | 2599 |
|
|
2021
Q4 | $2K | Sell |
68
-61
| -47% | -$1.79K | ﹤0.01% | 2737 |
|
|
2021
Q3 | $5K | Buy |
129
+63
| +95% | +$2.44K | ﹤0.01% | 2360 |
|
|
2021
Q2 | $3K | Buy |
66
+16
| +32% | +$727 | ﹤0.01% | 2462 |
|
|
2021
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 2487 |
|
|
2020
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 2322 |
|
|
2020
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 2460 |
|
|
2020
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 2352 |
|
|
2020
Q1 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 2316 |
|